Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:21419770rdf:typepubmed:Citationlld:pubmed
pubmed-article:21419770lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:21419770lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:21419770lifeskim:mentionsumls-concept:C0524910lld:lifeskim
pubmed-article:21419770lifeskim:mentionsumls-concept:C0796545lld:lifeskim
pubmed-article:21419770lifeskim:mentionsumls-concept:C0677908lld:lifeskim
pubmed-article:21419770pubmed:issue7lld:pubmed
pubmed-article:21419770pubmed:dateCreated2011-6-6lld:pubmed
pubmed-article:21419770pubmed:databankReferencehttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:abstractTextSeveral studies have reported that low doses of interferon can delay the development of hepatocellular carcinoma (HCC) and progression of chronic hepatitis C. We investigated the incidence of clinical events among participants of the Evaluation of PegIntron in Control of Hepatitis C Cirrhosis (EPIC)3 program.lld:pubmed
pubmed-article:21419770pubmed:languageenglld:pubmed
pubmed-article:21419770pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:citationSubsetAIMlld:pubmed
pubmed-article:21419770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:21419770pubmed:statusMEDLINElld:pubmed
pubmed-article:21419770pubmed:monthJunlld:pubmed
pubmed-article:21419770pubmed:issn1528-0012lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:ColomboMassim...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:PoynardThierr...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:BruixJordiJlld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:BedossaPierre...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:AlbrechtJanic...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:BoparaiNavdee...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:NiederauClaus...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:BergThomasTlld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:SchiffEugeneElld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:GriffelLouis...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:TergRubenRlld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:BurakKellyKlld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:BrassClifford...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:BurroughsMarg...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:HeathcoteEliz...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:PooJorge-Luis...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:MelloCarlos...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:GuentherRaine...lld:pubmed
pubmed-article:21419770pubmed:authorpubmed-author:EPIC3 Study...lld:pubmed
pubmed-article:21419770pubmed:copyrightInfoCopyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.lld:pubmed
pubmed-article:21419770pubmed:issnTypeElectroniclld:pubmed
pubmed-article:21419770pubmed:volume140lld:pubmed
pubmed-article:21419770pubmed:ownerNLMlld:pubmed
pubmed-article:21419770pubmed:authorsCompleteYlld:pubmed
pubmed-article:21419770pubmed:pagination1990-9lld:pubmed
pubmed-article:21419770pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:meshHeadingpubmed-meshheading:21419770...lld:pubmed
pubmed-article:21419770pubmed:year2011lld:pubmed
pubmed-article:21419770pubmed:articleTitleMaintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.lld:pubmed
pubmed-article:21419770pubmed:affiliationBCLC Group, Liver Unit, Hospital Clinic of Barcelona, University of Barcelona, IDIBAPS, Centro de Investigación Biomédica en Red de Hepatología y Enfermedades Digestivas, Barcelona, Spain. jbruix@clinic.ub.eslld:pubmed
pubmed-article:21419770pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:21419770pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:21419770pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:21419770pubmed:publicationTypeMulticenter Studylld:pubmed